Semaglutide + Tirzepatide + Retatrutide

Semaglutide, Tirzepatide, and Retatrutide are peptides that draw inspiration from natural gut hormones involved in regulating glucose and appetite. Semaglutide, a GLP-1 analog, enhances insulin secretion and suppresses glucagon release. Tirzepatide serves as a dual agonist for GIP and GLP-1 receptors, amplifying metabolic effects. Retatrutide, a triple agonist, adds an extra dimension by targeting the glucagon receptor as well. Research on Semaglutide + Tirzepatide + Retatrutide began with their potential to manage metabolic disorders, sparking interest in their combined efficacy. This trio functions by modulating multiple metabolic pathways, offering a layered approach to glucose regulation. Today, it is primarily studied for its effects on:

• Metabolic pathway modulation
• Glucose homeostasis
• Appetite regulation
• Insulin sensitivity

This combination has spurred further studies into its potential effects on weight management and energy balance.

PeptideSource editorial · Updated Jul 19, 2026